SAFESCIENCE INC
8-K, EX-99.1, 2000-06-06
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SAFESCIENCE INC, 8-K, 2000-06-06
Next: SAFESCIENCE INC, 8-K, EX-99.2, 2000-06-06



KCSA
Public Relations
WORLDWIDE                                                                   NEWS
--------------------------------------------------------------------------------
Public & Investor Relations, Corporate & Marketing Communications


FOR:              SAFESCIENCE, INC.

CONTACTS:         Rick Pierce
                  617-422-0674
                  [email protected]

KCSA              Bonnie Stretch/Paul Holm
CONTACTS          212-896-1206/896-1201
                  [email protected]/[email protected]
                  --------------------------------
                  www.kcsa.com


                                                           FOR IMMEDIATE RELEASE
                                                           ---------------------



                   SAFESCIENCE, INC. ANNOUNCES APPOINTMENTS OF
                BRADLEY J. CARVER AS NEW CHIEF EXECUTIVE OFFICER,
                      BRIAN HUGHES AS CHAIRMAN OF THE BOARD


Boston,   MA  -  May  31,  2000  -   SafeScience,   Inc.   (NASDAQ:   SAFS),   a
biotechnology-based  developer and marketer of chemically  safe  pharmaceutical,
agricultural,  and consumer products, today announced the appointment of Bradley
J. Carver, President, as the company's new Chief Executive Officer. Mr. Carver's
appointment is effective immediately.  He retains his title as President.  Board
member Brian G. R. Hughes has been named Chairman of the Board.

Mr. Carver,  co-Founder of the company,  has served as President  since 1994. He
has overseen the company's  diversification  from pharmaceutical to agricultural
products and the consumer  and  industrial  markets.  Under his  direction,  the
Company  saw its first  revenues  in 1999 and made  advances in all areas of the
business,  from research and development to expanded product lines and new sales
and distribution channels.

Brian G.R.  Hughes has been a director of the Company since  December  1998. Mr.
Hughes  is  president  of  the   Association   of  Alumni  and  Alumnae  of  the
Massachusetts  Institute of Technology  (MIT).  Since July 1978,  Mr. Hughes has
held a variety of  positions  with the MIT  Corporation,  the board that governs
MIT. From  February  1989 through  April 1995,  Mr. Hughes was Vice Chairman and
then CEO of American Rocket Company,  which worked to develop and  commercialize
safe, clean, low-cost hybrid rocket propulsion.

The SafeScience management team remains otherwise unchanged.  John W. Burns, the
Company's  Chief  Financial  Officer,  has a broad  senior  financial  executive
background in

<PAGE>






industrial, financial and health care industries. He has served as CFO for South
Shore Hospital in South Weymouth,  Massachusetts, and has held corporate finance
and  treasury  positions  with  Eastern  Enterprises,   Allied-Signal,  Citicorp
Investment  Bank, and  International  Paper.  Kenneth J. Smaha,  Chief Operating
Officer,  has 30 years'  experience  in  strategic,  operational,  and financial
management  in  the  consumer   packaged  goods  and  industrial   manufacturing
industries.

Strengthening  its product  development  and  distribution,  SafeScience has key
relationships in several industries,  including Covance  Incorporated,  a global
leader in contract drug development,  and Daymon Associates, a leading corporate
branding and retail sales company with offices in 16 countries.


--------------------------------------------------------------------------------


Except for historical  information contained herein, the statements made in this
release  constitute  forward-looking  statements  that involve certain risks and
uncertainties.  Certain  factors may cause actual  results to differ  materially
from those contained in the forward-looking statements, including general market
conditions,  factors  relating  to  risk  of  product  non-approval  or  product
development and market acceptance risks, the impact of competitive  products and
pricing,  the results of current and future  licensing  and other  collaborative
relationships,   the  results  of  financing  efforts,   developments  regarding
intellectual property rights and litigation,  and other risks detailed from time
to  time  in  SafeScience's  reports  on file  at the  Securities  and  Exchange
Commission, including SafeScience's Form 10-K for the fiscal year ended December
31,  1999 and  SafeScience's  Form 10-Q for the fiscal  quarter  ended March 31,
2000. The Company  disclaims any intention or obligation to update or revise any
forward-looking  statements,  whether  as a result  of new  information,  future
events or otherwise.

This press release is available on the KCSA Public Relations  Worldwide Web site
at www.kcsa.com.
   ------------



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission